Launch week: the AltIndex Developer API is live. 25% off all plans with code LAUNCHWEEKSee plans
22
Search trend (0 - 100) on Google Search. Updated Jun 13, 2026
Loading...

Similar companies

Is Pfizer Trending on Google?

Pfizer has a Google Trends score of 22/100, a relative measure of search interest over the trailing 12 months (100 marks the peak in that window). This is relatively low search interest, which can mean Pfizer is flying under the mainstream radar. Search interest is down 60.0% over the past three months. Google Trends captures attention from the broadest audience — consumers, job seekers and the general public, not just investors.

How Google Search Interest Impacts PFE’s AI Score

Search spikes often line up with earnings, product launches and viral news, and a sustained shift in consumer attention can precede changes in demand. AltIndex feeds Pfizer’s Google Trends score into the PFE AI Score as one of 25+ alternative data signals, weighed against web traffic, app downloads, sentiment and fundamentals rather than read in isolation.

For other demand signals, see Pfizer’s Reddit mentions, web traffic, app downloads, and news mentions.

Pfizer Google Trends: Frequently Asked Questions

Pfizer's Google Trends score is 22/100. Search interest is currently low. A score of 100 represents peak search interest within the trailing 12 months.

Not on its own. Google Trends spikes often coincide with higher trading volume and short-term price moves around earnings and news events, but search interest is not a reliable directional predictor by itself. AltIndex combines PFE's search interest with 25+ other signals in its AI Score rather than reading any one signal in isolation.

A Google Trends score is a relative index from 0 to 100 that measures search interest over time: 100 marks the highest point in the selected period and 50 is half that level. It reflects relative popularity, not an absolute number of searches.

Pfizer overperforms a majority of its industry peers when it comes to Google Trends, ranking in the 63rd percentile.

Sign up and get more insights on Pfizer.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.